Edgar Mendoza-Gamboa

871 total citations
27 papers, 709 citations indexed

About

Edgar Mendoza-Gamboa is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Edgar Mendoza-Gamboa has authored 27 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Immunology and 5 papers in Oncology. Recurrent topics in Edgar Mendoza-Gamboa's work include Immunotherapy and Immune Responses (5 papers), Immune Response and Inflammation (4 papers) and Cancer Research and Treatments (3 papers). Edgar Mendoza-Gamboa is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Response and Inflammation (4 papers) and Cancer Research and Treatments (3 papers). Edgar Mendoza-Gamboa collaborates with scholars based in Mexico and United States. Edgar Mendoza-Gamboa's co-authors include Cristina Rodrı́guez-Padilla, Pablo Zapata‐Benavides, Moisés Ármides Franco-Molina, Denis Ricque-Marie, Lucía Elizabeth Cruz‐Suárez, Laura Trejo‐Avila, Reyes Támez-Guerra, Regina Elizondo‐González, Juan Manuel Alcocer-González and Reyes S. Taméz-Guerra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Marine Drugs and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Edgar Mendoza-Gamboa

27 papers receiving 681 citations

Peers

Edgar Mendoza-Gamboa
Pablo Zapata‐Benavides Mexico
Tingting Hu China
Haiting Xu China
Shangyong Li China
Animesh Kumar India
Mengmeng Lu China
Jeffrey D. Konowalchuk Canada
Paula Parreira Portugal
Paulina Sawicka Poland
Pablo Zapata‐Benavides Mexico
Edgar Mendoza-Gamboa
Citations per year, relative to Edgar Mendoza-Gamboa Edgar Mendoza-Gamboa (= 1×) peers Pablo Zapata‐Benavides

Countries citing papers authored by Edgar Mendoza-Gamboa

Since Specialization
Citations

This map shows the geographic impact of Edgar Mendoza-Gamboa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Mendoza-Gamboa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Mendoza-Gamboa more than expected).

Fields of papers citing papers by Edgar Mendoza-Gamboa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar Mendoza-Gamboa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Mendoza-Gamboa. The network helps show where Edgar Mendoza-Gamboa may publish in the future.

Co-authorship network of co-authors of Edgar Mendoza-Gamboa

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar Mendoza-Gamboa. A scholar is included among the top collaborators of Edgar Mendoza-Gamboa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar Mendoza-Gamboa. Edgar Mendoza-Gamboa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zapata‐Benavides, Pablo, et al.. (2021). The Inflammatory Process Modulates the Expression and Localization of WT1 in Podocytes Leading to Kidney Damage. In Vivo. 35(6). 3137–3146. 11 indexed citations
2.
Zapata‐Benavides, Pablo, et al.. (2019). shRNA-WT1 Potentiates Anticancer Effects of Gemcitabine and Cisplatin Against B16F10 Lung MetastasesIn VitroandIn Vivo. In Vivo. 33(3). 777–785. 2 indexed citations
3.
Franco-Molina, Moisés Ármides, Carlos E. Hernández-Luna, Diana Zárate-Triviño, et al.. (2018). Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment. Biotechnology & Biotechnological Equipment. 32(4). 1028–1035. 6 indexed citations
4.
Franco-Molina, Moisés Ármides, et al.. (2018). Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate. Immunopharmacology and Immunotoxicology. 40(5). 437–443. 2 indexed citations
5.
Franco-Molina, Moisés Ármides, Edgar Mendoza-Gamboa, Ana Carolina Martínez‐Torres, et al.. (2017). The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth. Oncology Letters. 14(1). 844–852. 22 indexed citations
6.
Franco-Molina, Moisés Ármides, et al.. (2016). Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment. OncoTargets and Therapy. 9. 243–243. 14 indexed citations
7.
Franco-Molina, Moisés Ármides, et al.. (2016). Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells. Oncology Letters. 12(6). 4449–4460. 5 indexed citations
8.
Aguilar-Briseño, José A., Lucía Elizabeth Cruz‐Suárez, Jean‐François Sassi, et al.. (2015). Sulphated Polysaccharides from Ulva clathrata and Cladosiphon okamuranus Seaweeds both Inhibit Viral Attachment/Entry and Cell-Cell Fusion, in NDV Infection. Marine Drugs. 13(2). 697–712. 131 indexed citations
9.
Franco-Molina, Moisés Ármides, Edgar Mendoza-Gamboa, Pablo Zapata‐Benavides, et al.. (2013). Expression of Foxp3, CD25 and IL-2 in the B16F10 cancer cell line and melanoma is correlated with tumor growth in mice. Oncology Letters. 6(5). 1195–1200. 15 indexed citations
10.
Elizondo‐González, Regina, Lucía Elizabeth Cruz‐Suárez, Denis Ricque-Marie, et al.. (2012). In vitro characterization of the antiviral activity of fucoidan from Cladosiphon okamuranus against Newcastle Disease Virus. Virology Journal. 9(1). 307–307. 116 indexed citations
11.
Franco-Molina, Moisés Ármides, et al.. (2010). Antiangiogenic and antitumor effects of IMMUNEPOTENT CRP in murine melanoma. Immunopharmacology and Immunotoxicology. 32(4). 637–646. 16 indexed citations
12.
Franco-Molina, Moisés Ármides, Edgar Mendoza-Gamboa, Ricardo Gomez‐Flores, et al.. (2010). Antitumor activity of colloidal silver on MCF-7 human breast cancer cells. Journal of Experimental & Clinical Cancer Research. 29(1). 148–148. 154 indexed citations
13.
Franco-Molina, Moisés Ármides, Edgar Mendoza-Gamboa, Pablo Zapata‐Benavides, et al.. (2008). IMMUNEPOTENT CRP (bovine dialyzable leukocyte extract) adjuvant immunotherapy: a phase I study in non-small cell lung cancer patients. Cytotherapy. 10(5). 490–496. 25 indexed citations
14.
15.
Franco-Molina, Moisés Ármides, et al.. (2007). Bovine dialyzable leukocyte extract modulates cytokines and nitric oxide production in lipopolysaccharide-stimulated human blood cells. Cytotherapy. 9(4). 379–385. 10 indexed citations
16.
Franco-Molina, Moisés Ármides, et al.. (2006). In vitro effects of bovine dialyzable leukocyte extract (bDLE) in cancer cells. Cytotherapy. 8(4). 408–414. 26 indexed citations
17.
Franco-Molina, Moisés Ármides, Edgar Mendoza-Gamboa, Reyes Támez-Guerra, et al.. (2006). In VitroAntibacterial Activity of Bovine Dialyzable Leukocyte Extract. Immunopharmacology and Immunotoxicology. 28(3). 471–483. 7 indexed citations
18.
19.
Mendoza-Gamboa, Edgar, Doris R. Siwak, & Ana M. Tari. (2004). The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells. Oncology Reports. 12(4). 903–8. 7 indexed citations
20.
Franco-Molina, Moisés Ármides, et al.. (2004). Bovine dialyzable leukocyte extract protects against LPS-induced, murine endotoxic shock. International Immunopharmacology. 4(13). 1577–1586. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pablo Zapata‐Benavides Breakdown of academic impact, for papers by Tingting Hu Breakdown of academic impact, for papers by Haiting Xu Breakdown of academic impact, for papers by Shangyong Li Breakdown of academic impact, for papers by Animesh Kumar Breakdown of academic impact, for papers by Mengmeng Lu Breakdown of academic impact, for papers by Jeffrey D. Konowalchuk Breakdown of academic impact, for papers by Paula Parreira Breakdown of academic impact, for papers by Paulina Sawicka
Rankless by CCL
2026